ESR1 and metastatic malignant neoplasm in the lymph nodes: Many factors, such as tumor type, histological grade, lymph node metastasis, estrogen receptor (ER), and progesterone receptor (PR), affect the treatment response and prognosis of BC (Jokar et al., 2021).